News Agency
Men's Weekly

Abivax receives ANSM and Ethics Committee clearance to test its development candidate ABX464 in 1,034 Covid-19 patients in randomized Phase 2b/3 clinical trial

  • Written by Media Outreach
  • French regulator, ANSM, as well as Ethics Committee, CPP, have cleared ABX464 for Phase 2b/3 "miR-AGE" testing
  • The anti-inflammatory mechanism of action could prevent and treat cytokine storm and hyper-inflammation, which lead to acute respiratory distress syndrome (ARDS) and death of COVID-19 patients
  • New data[1] show ABX464 inhibits SARS-CoV-2...

Read more: Abivax receives ANSM and Ethics Committee clearance to test its development candidate ABX464 in...

Managing Business Risk Through Content Governance in Headless CMS

As businesses scale their digital presence, content becomes a critical asset that directly impacts reputation, compliance, and operational efficiency. However, without proper governance, content can quickly become a source of risk. Inaccurate information, inconsistent messaging, or non-compliant content can lead... Read more

Writers Wanted



NewsServices.com

Content & Technology Connecting Global Audiences

More Information - Less Opinion